Skip to main content
Premium Trial:

Request an Annual Quote

Updating the Public

At AMP's annual meeting last week, NIH's Cathy Fomous stopped by to give the members an update on the organization's plans for a Genetic Testing Registry — NIH intends the registry, which is voluntary, to be a comprehensive source about all the genetic tests available to the public, she said. After a period of public comment, conversations with stakeholders and partners, and a public stakeholder meeting at ASHG earlier this month, NIH received strong support for the registry from industry and academia, though there were also several concerns, Fomous said. Survey respondents stressed a need to ensure the accuracy of the registry information and were concerned about the potential harm to patients should the information in the registry be inaccurate, incomplete, or misinterpreted. At this point, Fomous said, NIH will be analyzing the comments, convening focus groups on the registry prototype, and developing and beta testing the registry. NIH aims to launch the registry in the spring.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.